IPC
SPPI

Independent Portfolio Consultants’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Independent Portfolio Consultants’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,135
Closed -$63K – 1053
2014
Q4 		$63K Buy
+9,135
New +$67.2K 0.01% 601

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Independent Portfolio Consultants's SPPI Position: Q1 2015 in Review

Independent Portfolio Consultants sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2015, closing a stake of 9,135 shares — an estimated $63K sold.

Independent Portfolio Consultants first reported a position in SPPI in Q4 2014 and held it in 1 quarter. The position peaked at $63K in Q4 2014. 137 funds tracked by Wall St. Rank hold SPPI as of Q1 2015.

  • Independent Portfolio Consultants reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 9,135 Spectrum Pharmaceuticals Inc shares in Q1 2015, an estimated $63K.
  • Independent Portfolio Consultants first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 1 quarter.
  • Independent Portfolio Consultants's Spectrum Pharmaceuticals Inc position peaked at $63K in Q4 2014.
  • 137 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2015.

Based on Independent Portfolio Consultants's 13F filing for Q1 2015, filed 27 May 2015.